Clinical studies recruiting near Madison

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The RECAP2 Study: Midazolam and Psilocybin
Phase 1 · UW School of Medicine and Public Health · University of Wisconsin, Madison · NCT06692192 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · University of Wisconsin · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · University of Wisconsin Carbone Cancer Center - Eastpark Med · Pfizer · NCT07028853 Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · William S. Middleton Memorial Veterans Hospital, Madison, WI · VA Office of Research and Development · NCT06625073 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · SSM Health Dean Medical Group - South Madison Campus Health · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · SSM Health Dean Medical Group ( Site 0087) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · William S Middleton VA Medical Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · University of Wisconsin Carbone Cancer Center - University H · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · University of Wisconsin Carbone Cancer Center - University H · National Cancer Institute (NCI) · NCT06172296 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · University of Wisconsin · Vertex Pharmaceuticals Incorporated · NCT04786262 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Michigan Healthcare Professionals Madison Heights · NRG Oncology · NCT05624996 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · University of Wisconsin, Madison · Relay Therapeutics, Inc. · NCT06789913 A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · UW Health · Verastem, Inc. · NCT07644559 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · William S Middleton VA Medical Center · Alliance for Clinical Trials in Oncology · NCT07321652 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · University of Wisconsin Carbone Cancer Center - University H · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · University of Wisconsin Carbone Cancer Center - University H · National Cancer Institute (NCI) · NCT05691478 Sparking Potential, Revealing Infant Neurocognitive Traits
Phase N/A · University of Wisconsin-Madison School of Medicine and Publi · University of Wisconsin, Madison · NCT07390136 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · Univeristy of Wisconsin · Greg Durm, MD · NCT04317534 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · University of Wisconsin Carbone Cancer Center - Eastpark Med · National Cancer Institute (NCI) · NCT04172532 The Advancing Dynamic And Personalized Training Study
NA · Center for Healthy Minds · University of Wisconsin, Madison · NCT07051330 Testing MOUD Scale-Up
NA · University of Wisconsin-Madison · University of Wisconsin, Madison · NCT07224516 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · University of Wisconsin Carbone Cancer Center - Eastpark Med · National Cancer Institute (NCI) · NCT06860594 A Study of Mirikizumab Solution (LY3074828) in Healthy Participants
Phase 1 · Fortrea Clinical Research Unit · Eli Lilly and Company · NCT07446101 Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · University of Wisconsin Carbone Cancer Center - Eastpark Med · National Cancer Institute (NCI) · NCT05691465 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Alliance for Clinical Trials in Oncology · NCT07091617 RESISTance Exercise for Depression Trial
NA · University of Wisconsin - Madison · University of Wisconsin, Madison · NCT06110897 Study of 18F-FFNP Breast PET/MRI
Phase 2 · UW Carbone Cancer Center · University of Wisconsin, Madison · NCT06086704 Evaluation of Pediatric eCART Implementation
NA · American Family Children's Hospital · University of Wisconsin, Madison · NCT06771830

Look up another city

Look up another condition